Cibc World Market Inc. Amicus Therapeutics, Inc. Transaction History

Cibc World Market Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$13.47 - $24.89 $487,829 - $901,416	-36,216 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $7,076 - $8,723	549 Added 1.54%	36,216 $511,000
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $316,009 - $559,615	35,667 New	35,667 $538,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.